CHE - Chemed Corporation
NYSE
->
Healthcare
->
Medical Care Facilities
Cincinnati,
United States
Type: Equity
CHE price evolution
CHE
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $263.96 | $173.15 | $159.92 | $58.05 |
| Short term investments | ||||
| Net receivables | $181.51 | $168.03 | $120.31 | $153.82 |
| Inventory | $12 | $12.51 | $11.68 | $10.66 |
| Total current assets | $500.84 | $394.54 | $337.16 | $262.22 |
| Long term investments | $106.13 | $104.41 | $99.52 | $97.44 |
| Property, plant & equipment | $330.23 | $328.81 | $335.32 | $335.38 |
| Goodwill & intangible assets | $675.28 | $677.75 | $676.47 | $678.63 |
| Total noncurrent assets | $1167.25 | $1167.54 | $1168.02 | $1168.96 |
| Total investments | $106.13 | $104.41 | $99.52 | $97.44 |
| Total assets | $1668.1 | $1562.08 | $1505.18 | $1431.18 |
| Current liabilities | ||||
| Accounts payable | $64.03 | $56.51 | $41.06 | $40.28 |
| Deferred revenue | ||||
| Short long term debt | $38.63 | $37.62 | $38.78 | $43.29 |
| Total current liabilities | $312.05 | $297.22 | $302.49 | $283.46 |
| Long term debt | $99.35 | $102.11 | $122.46 | |
| Total noncurrent liabilities | $248.17 | $245.62 | $250.61 | $267.67 |
| Total debt | $38.63 | $136.96 | $140.89 | $165.75 |
| Total liabilities | $560.22 | $542.84 | $553.1 | $551.13 |
| Shareholders' equity | ||||
| Retained earnings | $2446.93 | $2362.93 | $2294 | $2246.35 |
| Other shareholder equity | $2.08 | $2.05 | $2.32 | $2.28 |
| Total shareholder equity | $1107.88 | $1019.24 | $952.08 | $880.05 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $263.96 | $74.13 | $32.9 | $162.68 |
| Short term investments | ||||
| Net receivables | $181.51 | $139.41 | $137.22 | $126.85 |
| Inventory | $12 | $10.27 | $10.11 | $7.09 |
| Total current assets | $500.84 | $272.61 | $230.29 | $329.4 |
| Long term investments | $106.13 | $93.2 | $98.88 | $88.81 |
| Property, plant & equipment | $330.23 | $335.38 | $318.73 | $311.27 |
| Goodwill & intangible assets | $675.28 | $681.02 | $686.69 | $696.67 |
| Total noncurrent assets | $1167.25 | $1169.4 | $1112.44 | $1105.51 |
| Total investments | $106.13 | $93.2 | $98.88 | $88.81 |
| Total assets | $1668.1 | $1442.01 | $1342.72 | $1434.91 |
| Current liabilities | ||||
| Accounts payable | $64.03 | $41.88 | $73.02 | $54.23 |
| Deferred revenue | ||||
| Short long term debt | $38.63 | $44 | $37.91 | $36.2 |
| Total current liabilities | $312.05 | $297.2 | $302.4 | $299.11 |
| Long term debt | $92.5 | $185 | ||
| Total noncurrent liabilities | $248.17 | $346.09 | $417.05 | $234.6 |
| Total debt | $38.63 | $136.5 | $222.91 | $36.2 |
| Total liabilities | $560.22 | $643.3 | $719.45 | $533.71 |
| Shareholders' equity | ||||
| Retained earnings | $2446.93 | $2197.92 | $1970.31 | $1723.78 |
| Other shareholder equity | $2.08 | $2.25 | $2.2 | $2.76 |
| Total shareholder equity | $1107.88 | $798.72 | $623.27 | $901.2 |
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $564.53 | $553.82 | $560.16 | |
| Cost of revenue | $362.36 | $374.19 | $370.7 | |
| Gross Profit | $202.17 | $179.62 | $189.45 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $99.6 | $94.99 | $100.09 | |
| Total operating expenses | $115.32 | $110.12 | $116.63 | |
| Operating income | $86.85 | $69.51 | $72.82 | |
| Income from continuing operations | ||||
| EBIT | $93.71 | $71.11 | $72.72 | |
| Income tax expense | $18.31 | $16.97 | $17.04 | |
| Interest expense | $0.44 | $0.77 | $1.55 | |
| Net income | ||||
| Net income | $74.96 | $53.38 | $54.12 | |
| Income (for common shares) | $74.96 | $53.38 | $54.12 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2264.42 | $2134.96 | $2139.26 | $2079.58 |
| Cost of revenue | $1465.6 | $1369.88 | $1369.46 | $1378.2 |
| Gross Profit | $798.82 | $765.09 | $769.8 | $701.39 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $395.12 | $358.73 | $366.73 | $330.22 |
| Total operating expenses | $458.25 | $421.59 | $426.76 | $311.71 |
| Operating income | $340.57 | $343.5 | $343.04 | $389.68 |
| Income from continuing operations | ||||
| EBIT | $353.48 | $334.26 | $352.18 | $398.35 |
| Income tax expense | $77.86 | $80.06 | $81.76 | $76.52 |
| Interest expense | $3.11 | $4.58 | $1.87 | $2.35 |
| Net income | ||||
| Net income | $272.51 | $249.62 | $268.55 | $319.47 |
| Income (for common shares) | $272.51 | $249.62 | $268.55 | $319.47 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $90.05 | $74.96 | $53.38 | $54.12 |
| Operating activities | ||||
| Depreciation | $15.54 | $15.38 | $15.15 | $14.8 |
| Business acquisitions & disposals | -$3.69 | -$0.3 | ||
| Stock-based compensation | $10.34 | $8.64 | $9.87 | $10.51 |
| Total cash flows from operations | $108.56 | $28.93 | $132.32 | $60.49 |
| Investing activities | ||||
| Capital expenditures | -$11.64 | -$11.51 | -$16.19 | -$16.87 |
| Investments | ||||
| Total cash flows from investing | -$11.67 | -$15.44 | -$16.52 | -$17.01 |
| Financing activities | ||||
| Dividends paid | -$6.06 | -$6.03 | -$5.73 | -$5.68 |
| Sale and purchase of stock | $3.99 | -$9.74 | $14.57 | $25.68 |
| Net borrowings | -$0.43 | $16.18 | -$21.25 | -$76.25 |
| Total cash flows from financing | -$6.08 | -$0.26 | -$13.93 | -$59.55 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $90.81 | $13.23 | $101.87 | -$16.07 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $272.51 | $249.62 | $268.55 | $319.47 |
| Operating activities | ||||
| Depreciation | $60.87 | $59.17 | $59.05 | $56.58 |
| Business acquisitions & disposals | -$3.99 | -$3.53 | -$3.6 | |
| Stock-based compensation | $39.35 | $32.44 | $30.25 | $26.8 |
| Total cash flows from operations | $330.3 | $309.89 | $308.6 | $489.29 |
| Investing activities | ||||
| Capital expenditures | -$56.21 | -$54.99 | -$58.67 | -$58.83 |
| Investments | ||||
| Total cash flows from investing | -$60.64 | -$59.4 | -$57.76 | -$61.56 |
| Financing activities | ||||
| Dividends paid | -$23.5 | -$22.02 | -$22.02 | -$21.08 |
| Sale and purchase of stock | $34.49 | -$69.55 | -$576.04 | -$175.59 |
| Net borrowings | -$81.75 | -$100.97 | $196.88 | -$99.85 |
| Total cash flows from financing | -$79.83 | -$209.25 | -$380.62 | -$271.21 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $189.83 | $41.23 | -$129.78 | $156.52 |
News
Fundamentals
| Market cap | $9.29B |
|---|---|
| Enterprise value | $9.07B |
| Shares outstanding | 15.03M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 8.40 |
| Book/Share | 73.55 |
| Cash/Share | 17.56 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.51 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.61 |
| Quick ratio | 1.57 |